FIM
ALIM

Freedom Investment Management’s Alimera Sciences ALIM Stock Holding History

Freedom Investment Management’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-820
Closed -$13K – 743
2019
Q1 		$13K Buy
+820
New +$12.5K ﹤0.01% 680

Other funds holding ALIM

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Freedom Investment Management's ALIM Position: Q2 2019 in Review

Freedom Investment Management sold out of Alimera Sciences (ALIM) in Q2 2019, closing a stake of 820 shares — an estimated $13K sold.

Freedom Investment Management first reported a position in ALIM in Q1 2019 and held it in 1 quarter. The position peaked at $13K in Q1 2019. 41 funds tracked by Wall St. Rank hold ALIM as of Q2 2019.

  • Freedom Investment Management reported no remaining Alimera Sciences position as of Q2 2019 after selling out during the quarter.
  • Freedom Investment Management sold 820 Alimera Sciences shares in Q2 2019, an estimated $13K.
  • Freedom Investment Management first reported a position in Alimera Sciences in Q1 2019 and held it in 1 quarter.
  • Freedom Investment Management's Alimera Sciences position peaked at $13K in Q1 2019.
  • 41 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2019.

Based on Freedom Investment Management's 13F filing for Q2 2019, filed 18 Jul 2019.